tradingkey.logo

MedinCell: FDA Approves Expanded Indication For Uzedy

ReutersOct 13, 2025 7:27 AM

- Medincell SA MEDCL.PA:

  • ANNOUNCED ON FRIDAY THAT FDA APPROVED EXPANDED INDICATION FOR UZEDY (RISPERIDONE) EXTENDED-RELEASE INJECTABLE SUSPENSION AS A TREATMENT FOR ADULTS LIVING WITH BIPOLAR I DISORDER

  • JOINT ANNOUNCEMENT WITH TEVA PHARMACEUTICALS TEVA.TA

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI